Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Escalating Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days When Used on Full Face, Full Balding Scalp or Approximately 250 cm2 on the Chest in Subjects With Actinic Keratosis

NCT01820260 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01820260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01820260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Escalating Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days When Used on Full Face, Full Balding Scalp or Approximately 250 cm2 on the Chest in Subjects With Actinic Keratosis
Lead sponsor
LEO Pharma
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2013
Completion date
August 31, 2014
Enrollment
395 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis